NCT03880513View on ClinicalTrials.gov

Cardiovascular Status in Patients With Endogenous Cortisol Excess (Cushing's Syndrome)

CompletedOBSERVATIONAL

Enrollment

108

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions

Endogenous Cushing's Syndrome

Interventions

DIAGNOSTIC_TEST

Cardiovascular status and quality of life

Psychosocial and cardiovascular evaluation includes medical history, physical examination, laboratory tests, analysis of endothelial function, 24h blood pressure profile, Holter ECG, transthoracic echocardiography, cardiac MRI, and quality of life assessment

Trial Locations (1)

97080

University Hospital Wuerzburg, Würzburg

All Listed Sponsors

lead

Wuerzburg University Hospital

OTHER

NCT03880513 - Cardiovascular Status in Patients With Endogenous Cortisol Excess (Cushing's Syndrome) | Biotech Hunter | Biotech Hunter